Name: Anbio Biotechnology (NNNN) Financial Statements
Creator: FinSpry

Anbio Biotechnology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Anbio Biotechnology income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	8.19	6.71	23.54	4.43
Cost of Revenue	2.30	3.35	10.98	1.89
Gross Profit	5.89	3.36	12.56	2.54
Operating Expenses
Research & Development	0.45	0.13	0.20	0.00
Selling, General & Administrative	3.44	1.27	2.17	0.09
Operating Expenses	3.89	1.40	2.37	0.09
Operating Income	2.00	1.96	10.20	2.46
Other Income/Expense
Interest Income	0.34	0.17	0.04	0.00
Interest Expense	0.00	0.00	0.01	0.00
Other Income/Expense	0.02	0.01	-0.22	0.08
Income
Income Before Tax	2.37	2.25	10.01	2.54
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	2.37	2.25	10.01	2.54
Net Income - Continuous Operations	2.37	2.25	10.01	2.54
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	2.37	2.27	10.03	2.54
EBIT	2.00	1.96	10.02	2.54
Depreciation & Amortization	0.00	0.01	0.01	0.00
Earnings Per Share
Basic EPS	-	-	-	-
Diluted EPS	-	-	-	-
Basic Shares Outstanding	42.29	21.44	143.89	100.00
Diluted Shares Outstanding	42.29	21.44	143.89	100.00